FdaApplication
ANDA 216021
Identifiers
- fda_app_no: ANDA216021
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2024-08-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | EQ 40MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product